Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant LOXL2 (Simtuzumab Biosimilar) antibody

This anti-LOXL2 (Simtuzumab Biosimilar) antibody is a Human Monoclonal antibody detecting LOXL2 (Simtuzumab Biosimilar) in BLI, ELISA, FACS, Func and SPR. Suitable for Human.
Catalog No. ABIN7675789
-15% Promotion 2026
$294.23
$346.15
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 11 Business Days

Quick Overview for Recombinant LOXL2 (Simtuzumab Biosimilar) antibody (ABIN7675789)

Target

LOXL2 (Simtuzumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
  • 1
Human

Clonality

  • 1
  • 1
Monoclonal

Conjugate

  • 2
This LOXL2 (Simtuzumab Biosimilar) antibody is un-conjugated

Application

Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Purpose

    Anti-LOXL2 Reference Antibody (simtuzumab)

    Sequence

    QVQLVQSGAE VKKPGASVKV SCKASGYAFT YYLIEWVRQA PGQGLEWIGV INPGSGGTNY NEKFKGRATI TADKSTSTAY MELSSLRSED TAVYFCARNW MNFDYWGQGT TVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS CSVMHEALHN HYTQKSLSLS LGK,DIVMTQTPLS LSVTPGQPAS ISCRSSKSLL HSNGNTYLYW FLQKPGQSPQ FLIYRMSNLA SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCMQHLEYP YTFGGGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC

    Characteristics

    Anti-LOXL2 Reference Antibody (simtuzumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Purity

    >95 %

    Isotype

    IgG4 S228P
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: LOXL2 inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    LOXL2 (Simtuzumab Biosimilar)

    Target Type

    Biosimilar

    Molecular Weight

    145.5 kDa

    UniProt

    Q9Y4K0
You are here:
Chat with us!